IOVS Stroke
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsujikawa, M.
Right arrow Articles by Tano, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsujikawa, M.
Right arrow Articles by Tano, Y.
(Investigative Ophthalmology and Visual Science. 2000;41:2466-2468.)
© 2000 by The Association for Research in Vision and Ophthalmology, Inc.

Rapid Detection of M1S1 Mutations by the Protein Truncation Test

Motokazu Tsujikawa1, Kaoru Tsujikawa1, Naoyuki Maeda1, Hitoshi Watanabe1, Yoshitsugu Inoue1, Yukihiko Mashima2, Yoshikazu Shimomura3 and Yasuo Tano1

1 From the Department of Ophthalmology, Osaka University Medical School; the 2 Department of Ophthalmology, Keio University School of Medicine; and the 3 Department of Ophthalmology, Kinki University School of Medicine, Japan.

PURPOSE. To determine a method of rapid detection of M1S1 gene mutations in patients with gelatinous droplike corneal dystrophy.

METHODS. Forty-one patients from 35 families with gelatinous drop-like corneal dystrophy were studied. The entire coding region of the M1S1 gene was screened using the protein truncation test (PTT), with a polymerase chain reaction fragment amplified from genomic DNA serving as a template of in vitro translation.

RESULTS. Homozygous or compound heterozygous mutations were detected in all patients by a single reaction of the PTT. This result matched those obtained using the polymerase chain reaction–restriction fragment length polymorphism and direct sequence analyses. The Q118X mutation was present in 63 of the 70 alleles, accounting for 90% of the disease-associated chromosomes in Japanese patients.

CONCLUSIONS. The PTT is useful for detecting mutations in the M1S1 gene. This technique showed that the Q118X mutation is a founder mutation in Japanese patients with gelatinous droplike corneal dystrophy, and it reflects the linkage disequilibrium reported previously.




This article has been cited by other articles:


Home page
IOVSHome page
A. Alavi, E. Elahi, M. H. Tehrani, F. A. Amoli, M.-A. Javadi, N. Rafati, M. Chiani, S. S. Banihosseini, B. Bayat, R. Kalhor, et al.
Four Mutations (Three Novel, One Founder) in TACSTD2 among Iranian GDLD Patients
Invest. Ophthalmol. Vis. Sci., October 1, 2007; 48(10): 4490 - 4497.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the Association for Research in Vision and Ophthalmology